Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Apperley

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|February 28, 2008
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins diseaseIan Gabriel, Jane Apperley, Mark Bower, et al.
British Journal of Haematology|June 28, 2020
Ruxolitinib for tocilizumab-refractory severe COVID-19 infectionAndrew J Innes, Lucy B Cook, Sasha Marks, et al.
Haematologica|February 4, 2014
Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantationAlois Gratwohl, Ronald Brand, Eoin McGrath, et al.
Blood|May 31, 2012
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinibDavid Marin, Corinne Hedgley, Richard E Clark, et al.
American Journal of Hematology|May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonizationGareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
Leukemia Research|October 29, 2024
The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysisSusanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, et al.
Leukemia|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemiaAndreas Hochhaus, Moshe Talpaz, Giuseppe Saglio, et al.
Blood Cancer Journal|February 13, 2024
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphomaDanmei Xu, Findlay Bewicke-Copley, Karina Close, et al.
Blood|August 14, 2010
Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal responseAya Kuwabara, Anna Babb, Amr Ibrahim, et al.
Leukemia & Lymphoma|April 23, 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemiaGeorge Nesr, Simone Claudiani, Dragana Milojkovic, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|February 28, 2008
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins diseaseIan Gabriel, Jane Apperley, Mark Bower, et al.
British Journal of Haematology|June 28, 2020
Ruxolitinib for tocilizumab-refractory severe COVID-19 infectionAndrew J Innes, Lucy B Cook, Sasha Marks, et al.
Haematologica|February 4, 2014
Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantationAlois Gratwohl, Ronald Brand, Eoin McGrath, et al.
Blood|May 31, 2012
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinibDavid Marin, Corinne Hedgley, Richard E Clark, et al.
American Journal of Hematology|May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonizationGareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
Leukemia Research|October 29, 2024
The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysisSusanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, et al.
Leukemia|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemiaAndreas Hochhaus, Moshe Talpaz, Giuseppe Saglio, et al.
Blood Cancer Journal|February 13, 2024
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphomaDanmei Xu, Findlay Bewicke-Copley, Karina Close, et al.
Blood|August 14, 2010
Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal responseAya Kuwabara, Anna Babb, Amr Ibrahim, et al.
Leukemia & Lymphoma|April 23, 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemiaGeorge Nesr, Simone Claudiani, Dragana Milojkovic, et al.
Pageof 12